Joseph Michael Warusz
Keine laufenden Positionen mehr
Profil
Joseph Michael Warusz served as Chief Financial Officer, Secretary & VP at Soligenix, Inc. from 2012 to 2016.
Prior to that, he was the Chief Accounting Officer at NovaDel Pharma, Inc. and Vice President-Planning & Analysis at Orchid Cellmark, Inc. He also served as Vice President-Finance at Amicus Therapeutics, Inc. in 2005-2006.
In addition, he was the Chief Financial Officer, Secretary & Treasurer at Alliqua BioMedical, Inc. in 2018-2019.
Warusz earned an undergraduate degree in 1981 and an MBA in 1991, both from Drexel University.
Ehemalige bekannte Positionen von Joseph Michael Warusz
| Unternehmen | Position | Ende |
|---|---|---|
| SOLIGENIX, INC. | Director of Finance/CFO | 20.06.2016 |
| AMICUS THERAPEUTICS, INC. | Director of Finance/CFO | 01.03.2006 |
Alliqua BioMedical, Inc.
 Alliqua BioMedical, Inc. BiotechnologyHealth Technology Alliqua BioMedical, Inc. engages in commercializing differentiated regenerative medical products which assist the body in the repair or replacement of soft tissue. Its commercial wound care portfolio consists of wound bed preparation and human biologics. It also manufactures custom electron beam cross-linked and aqueous polymer hydrogels used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was founded on October 27, 1997 and is headquartered in Langhorne, PA. | Director of Finance/CFO | 18.03.2019 |
| NOVADEL PHARMA INC | Comptroller/Controller/Auditor | - |
Orchid Cellmark, Inc.
 Orchid Cellmark, Inc. Miscellaneous Commercial ServicesCommercial Services Orchid Cellmark, Inc. provides DNA testing services. It generates genetic profile information by analysing an organism's unique genetic identity. The firm also offers non-DNA forensic laboratory services. The company was founded on March 8, 1995 and is headquartered in Princeton, NJ. | Director of Finance/CFO | - |
Ausbildung von Joseph Michael Warusz
| Drexel University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| SOLIGENIX, INC. | Health Technology |
| AMICUS THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
NovaDel Pharma, Inc.
 NovaDel Pharma, Inc. Pharmaceuticals: MajorHealth Technology NovaDel Pharma, Inc. engages in developing oral spray formulations for different types of drugs. It develops oral spray and pharmaceutical products for angina pectoris, insomia, migraine headaches, and disorders of the central nervous system. The company was founded in 1982 and is headquartered in Bridgewater, NJ. | Health Technology |
Orchid Cellmark, Inc.
Orchid Cellmark, Inc. Miscellaneous Commercial ServicesCommercial Services Orchid Cellmark, Inc. provides DNA testing services. It generates genetic profile information by analysing an organism's unique genetic identity. The firm also offers non-DNA forensic laboratory services. The company was founded on March 8, 1995 and is headquartered in Princeton, NJ. | Commercial Services |
Alliqua BioMedical, Inc.
Alliqua BioMedical, Inc. BiotechnologyHealth Technology Alliqua BioMedical, Inc. engages in commercializing differentiated regenerative medical products which assist the body in the repair or replacement of soft tissue. Its commercial wound care portfolio consists of wound bed preparation and human biologics. It also manufactures custom electron beam cross-linked and aqueous polymer hydrogels used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was founded on October 27, 1997 and is headquartered in Langhorne, PA. | Health Technology |
